European Medicines Agency to review safety of GlaxoSmithKline’s diabetes drug Avandia

European agency to review safety of GSK’s Avandia

LONDON – The European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and deaths in older adults.
The agency said Friday that the review will be conducted by its Committee … Read this article on Gaea Times at : European Medicines Agency to review safety of GlaxoSmithKline’s diabetes drug Avandia.